QTX-1532

N/A

Report date: 2025/06/11 11:14:32

NME

Base Information

Drug NameQTX-1532

Drug Alias NameKRAS:RAF1 conformational modulators (Quanta Therapeutics)QTX-1532QTX-0001532-002

ClassificationSmall molecules

Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsMitogen-activated protein kinase inhibitorsAnticancer protein kinase inhibitors

TargetsGTPase KRasMitogen-activated protein kinase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesQuanta Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesQuanta Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A